1
Hazenberg, Bouke P. C., Croockewit, Alexandra, van der Holt, Bronno, Zweegman, Sonja, Bos, Gerard M. J., Delforge, Michel, Raymakers, Reinier A. P., Sonneveld, Pieter, Vellenga, Edo, Wijermans, Pierre W., von dem Borne, Peter A., van Oers, Marinus H., de Weerdt, Okke, Spoelstra, Fokje M., Lokhorst, Henk M.
Veröffentlicht in: Hazenberg , B P C , Croockewit , A , van der Holt , B , Zweegman , S , Bos , G M J , Delforge , M , Raymakers , R A P , Sonneveld , P , Vellenga , E , Wijermans , P W , von dem Borne , P A , van Oers , M H , de Weerdt , O , Spoelstra , F M & Lokhorst , H M 2015 , ' Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology ' , Haematologica-the Hematology Journal , vol. 100 , no. 5 , pp. 677-682 . https://doi.org/10.3324/haematol.2014.119198;
2015
Veröffentlicht in: Hazenberg , B P C , Croockewit , A , van der Holt , B , Zweegman , S , Bos , G M J , Delforge , M , Raymakers , R A P , Sonneveld , P , Vellenga , E , Wijermans , P W , von dem Borne , P A , van Oers , M H , de Weerdt , O , Spoelstra , F M & Lokhorst , H M 2015 , ' Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology ' , Haematologica-the Hematology Journal , vol. 100 , no. 5 , pp. 677-682 . https://doi.org/10.3324/haematol.2014.119198;
2015
2
Ossenkoppele, Gert J, Stussi, Georg, Maertens, Johan, van Montfort, Kees, Biemond, Bart J, Breems, Dimitri, Ferrant, August, Graux, Carlos, de Greef, Georgine E, Halkes, C J M, Hoogendoorn, Mels, Hollestein, Rene M, Jongen-Lavrencic, Mojca, Levin, Mark D, van de Loosdrecht, Arjan A, van Marwijk Kooij, Marinus, van Norden, Yvette, Pabst, Thomas, Schouten, Harry C, Vellenga, Edo, Verhoef, Gregor E G, de Weerdt, Okke, Wijermans, Pierre, Passweg, Jakob R, Löwenberg, Bob
2012
2012
3
Ossenkoppele, Gert Jan, Stussi, Georg, Maertens, Johan, van Montfort, Kees, Biemond, Bart J., Breems, Dimitri, Ferrant, August, Graux, Carlos, de Greef, Georgine E., Halkes, C. J. M., Hoogendoorn, Mels, Hollestein, Rene M., Jongen-Lavrencic, Mojca, Levin, Mark-David, van de Loosdrecht, Arjan A., Kooij, Marinus van Marwijk, van Norden, Yvette, Pabst, Thomas, Schouten, Harry C., Vellenga, Edo, Verhoef, Gregor E. G., de Weerdt, Okke, Wijermans, Pierre, Passweg, Jakob R., Lowenberg, Bob
Veröffentlicht in: Ossenkoppele , G J , Stussi , G , Maertens , J , van Montfort , K , Biemond , B J , Breems , D , Ferrant , A , Graux , C , de Greef , G E , Halkes , C J M , Hoogendoorn , M , Hollestein , R M , Jongen-Lavrencic , M , Levin , M-D , van de Loosdrecht , A A , Kooij , M V M , van Norden , Y , Pabst , T , Schouten , H C , Vellenga , E , Verhoef , G E G , de Weerdt , O , Wijermans , P , Passweg , J R & Lowenberg , B 2012 , ' Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK) ' , Blood , vol. 120 , no. 24 , pp. 4706-4711 . https://doi.org/10.1182/blood-2012-04-420596;
2012
Veröffentlicht in: Ossenkoppele , G J , Stussi , G , Maertens , J , van Montfort , K , Biemond , B J , Breems , D , Ferrant , A , Graux , C , de Greef , G E , Halkes , C J M , Hoogendoorn , M , Hollestein , R M , Jongen-Lavrencic , M , Levin , M-D , van de Loosdrecht , A A , Kooij , M V M , van Norden , Y , Pabst , T , Schouten , H C , Vellenga , E , Verhoef , G E G , de Weerdt , O , Wijermans , P , Passweg , J R & Lowenberg , B 2012 , ' Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK) ' , Blood , vol. 120 , no. 24 , pp. 4706-4711 . https://doi.org/10.1182/blood-2012-04-420596;
2012